These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8513091)

  • 1. [Disease caused by iron overload associated to minor beta thalassemia].
    García Pont J; Moreu Araño I; Asensio Montoro A; Rueda García A
    An Med Interna; 1993 Apr; 10(4):203. PubMed ID: 8513091
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 3 hemochromatosis and beta-thalassemia trait.
    Riva A; Mariani R; Bovo G; Pelucchi S; Arosio C; Salvioni A; Vergani A; Piperno A
    Eur J Haematol; 2004 May; 72(5):370-4. PubMed ID: 15059075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia.
    Breda L; Gardenghi S; Guy E; Rachmilewitz EA; Weizer-Stern O; Adamsky K; Amariglio N; Rechavi G; Giardina PJ; Grady RW; Rivella S
    Ann N Y Acad Sci; 2005; 1054():417-22. PubMed ID: 16339690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemochromatosis].
    Phlippen R
    Munch Med Wochenschr; 1972 Feb; 114(5):147-9. PubMed ID: 5066916
    [No Abstract]   [Full Text] [Related]  

  • 6. No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia.
    Origa R; Barella S; Argiolas GM; Bina P; Agus A; Galanello R
    Haematologica; 2008 Jul; 93(7):1095-6. PubMed ID: 18508795
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance.
    Nielsen P; Günther U; Dürken M; Fischer R; Düllmann J
    J Lab Clin Med; 2000 May; 135(5):413-8. PubMed ID: 10811057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload in thalassaemias and genetic haemochromatosis.
    Aguilar-Martinez P; Schved JF; Badens C; Thuret I; Michel G; Neonato MG; Peltier JY; Girot R; Pissard S; Galacteros F; Bachir D; Rose C; Picot MC; Denamur E; Elion J
    Eur J Haematol; 2000 Apr; 64(4):279-80. PubMed ID: 10776703
    [No Abstract]   [Full Text] [Related]  

  • 9. Iron overload in the liver diagnostic and quantification.
    Alústiza JM; Castiella A; De Juan MD; Emparanza JI; Artetxe J; Uranga M
    Eur J Radiol; 2007 Mar; 61(3):499-506. PubMed ID: 17166681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontransfusional iron overload in thalassemia: association with hereditary hemochromatosis.
    Rees DC; Luo LY; Thein SL; Singh BM; Wickramasinghe S
    Blood; 1997 Oct; 90(8):3234-6. PubMed ID: 9376610
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peculiarities of iron metabolism in patients with Beta - thalassemia at different periods after splenectomy].
    Kadimova E
    Georgian Med News; 2007 Nov; (152):35-7. PubMed ID: 18175831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Iron overload and hemochromatosis].
    Niederau C; Stremmel W; Strohmeyer G
    Internist (Berl); 1981 Sep; 22(9):546-54. PubMed ID: 7028669
    [No Abstract]   [Full Text] [Related]  

  • 13. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major.
    Au WY; Lam WW; Chu W; Tam S; Wong WK; Liang R; Ha SY
    Haematologica; 2008 Jan; 93(1):116-9. PubMed ID: 18166794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin.
    De Gobbi M; Pasquero P; Brunello F; Paccotti P; Mazza U; Camaschella C
    Haematologica; 2000 Aug; 85(8):865-7. PubMed ID: 10942934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ferrokinetic studies on patients with thalassemia minor].
    FEHR HU; MIESCHER P
    Schweiz Med Wochenschr; 1960 Oct; 90():1218-20. PubMed ID: 13698606
    [No Abstract]   [Full Text] [Related]  

  • 16. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major.
    Papakonstantinou O; Alexopoulou E; Economopoulos N; Benekos O; Kattamis A; Kostaridou S; Ladis V; Efstathopoulos E; Gouliamos A; Kelekis NL
    J Magn Reson Imaging; 2009 Apr; 29(4):853-9. PubMed ID: 19306409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepcidin: the Grail of iron metabolism].
    Loréal O; Brissot P
    Gastroenterol Clin Biol; 2002; 26(8-9):805-7. PubMed ID: 12434091
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of portable X-ray fluorescence (PXRF) in vivo as an alternative technique for the assessment of iron levels in patients with thalassemia and hemochromatosis.
    Estevam M; Appoloni CR
    Health Phys; 2013 Feb; 104(2):132-8. PubMed ID: 23274815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can iron chelators influence the progression of atherosclerosis?
    Marx JJ; Kartikasari AE; Georgiou NA
    Hemoglobin; 2008; 32(1-2):123-34. PubMed ID: 18274990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.